Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS). - Wikidata - wikimedia - TriplyDB

Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).

Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).

http://www.wikidata.org/entity/Q37068858

about

Psychometrics of a brief measure of anxiety to detect severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomized controlled trial.Brief intervention for anxiety in primary care patients.Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings.Dynamics of attentional bias to threat in anxious adults: bias towards and/or away?Mental health and substance use among bisexual youth and non-youth in Ontario, Canada Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.Cognitive-behavioral therapy for generalized anxiety disorder is associated with attenuation of limbic activation to threat-related facial emotions.Functioning and disability levels in primary care out-patients with one or more anxiety disorders.Changes in self-efficacy and outcome expectancy as predictors of anxiety outcomes from the CALM study.Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care Anxiety and depressive symptoms and medical illness among adults with anxiety disorders.Treatment engagement and response to CBT among Latinos with anxiety disorders in primary care Quality of and patient satisfaction with primary health care for anxiety disorders Assessing depression related severity and functional impairment: the Overall Depression Severity and Impairment Scale (ODSIS).Implementation of collaborative depression management at community-based primary care clinics: an evaluation.Are patient characteristics associated with quality of depression care and outcomes in collaborative care programs for depression?Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care.Occurrence of multiple mental health or substance use outcomes among bisexuals: a respondent-driven sampling study Abbreviated PTSD Checklist (PCL) as a guide to clinical response.LGB-affirmative cognitive-behavioral therapy for young adult gay and bisexual men: A randomized controlled trial of a transdiagnostic minority stress approach.A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.Course of symptom change during anxiety treatment: Reductions in anxiety and depression in patients completing the Coordinated Anxiety Learning and Management program.Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN)Sensitivity, specificity, and predictive power of the "Brief Risk-resilience Index for SCreening," a brief pan-diagnostic web screen for emotional health Cardiovascular Health in Anxiety or Mood Problems Study (CHAMPS): study protocol for a randomized controlled trial Longer-term increased cortisol levels in young people with mental health problems Collaborative care for the treatment of depression in primary care with a low-income, spanish-speaking population: outcomes from a community-based program evaluation Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety Trauma Exposure in Anxious Primary Care Patients.The Utility of the Family Empowerment Scale With Custodial Grandmothers.Age differences in treatment response to a collaborative care intervention for anxiety disorders Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study.Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.Suicidal ideation and risk factors in primary care patients with anxiety disorders.Anxiety treatment improves physical functioning with oblique scoring of the SF-12 short form health survey.Does a quality improvement intervention for anxiety result in differential outcomes for lower-income patients?Treatment for anxiety disorders: Efficacy to effectiveness to implementation.CBT competence in novice therapists improves anxiety outcomes

P2860

Q30497235-818DEE50-642D-44E5-AA4C-398DD2BF1BC0 Q33500848-9A99DE5B-0C6E-44E1-9606-C6D826DED324 Q33957348-BEA81AE7-2937-4F88-B745-2A90BD6DBEE2 Q34004272-1F3A3B15-61DC-4F1E-871E-9EDDAD3464BF Q34004954-1A85DD3A-BD63-4D2D-BE38-C134E33B7CCE Q34027185-642FCA13-9FED-490A-870E-33E1CF4B772B Q34085973-1D627192-61A0-4E18-AC47-400B0AA5734E Q34232195-2FC494AB-DCA7-452C-9A16-70F5E0E86C3C Q34247138-98E1ECA7-B09B-4A93-8E37-B9D0A51C1612 Q34572366-229B50DA-BD27-48A0-91DD-B5F2B3614DD4 Q34779556-9A5E338A-B764-4216-A102-D84B0626C6CA Q34979473-87180D92-5150-440C-B17E-9C0F04F08F66 Q34999866-BEC16BD4-106A-4D8B-8819-163796EF3CDF Q35036619-B4E7AAEF-6DA0-41F3-8AC8-894556F5D026 Q35394224-A66571BA-B484-4B47-A7D5-C02D0647BCD4 Q35648183-FE56E49C-1D1A-456D-8ECB-10C070D43FC6 Q35661225-FC36A547-9670-4372-A6B4-E2B0FC543DAC Q35923024-A3A6CFDE-C4CA-4931-910E-B1EDE0A95628 Q36048871-2288EDB4-B984-4C22-9DD1-C2DEFE819B40 Q36060714-AFADFBF8-9EFF-4FC1-8537-C6C275387ADB Q36068713-2CC5E174-D03B-4110-B29A-73F5E2332392 Q36254453-D29A301C-C52B-4BCC-A6B6-C61AA418BCC9 Q36307449-FD84BF99-C1AC-46FE-9AB1-BB0A60B8CCDD Q36315637-25CFC7FF-6212-42A4-9C3C-D162C88261C9 Q36373517-8F94C6D6-621A-4507-8583-D9DFFF7DA53F Q36449508-715E229F-C73F-4D39-B79C-38222C926B82 Q36587419-B80E54B2-3A0D-4552-B5B9-D2E44E0023A9 Q36755318-AB399D6D-3DE8-406E-8416-CDD45732CFE7 Q36816252-C10216FC-FB32-45A9-AD51-224349A8027F Q36887355-4ACEB511-0A22-471B-96B5-7B832412028D Q36913695-93FCA6AF-9CCC-4D83-A228-DB463EF28F4A Q36968081-50018E0E-F4DD-43A0-A976-830383CB04D8 Q36987340-2279A07D-BCA6-47AB-8B3E-3E962AE944EE Q37007298-0977D8AD-2F4F-4E84-97CB-807D8B1944FC Q37058478-059D2F47-94B7-4B63-A4F6-9C6B31E8539D Q37100857-77B9582A-5F83-4192-8979-FA1B701A9DB2 Q37106634-3E2F5317-6408-4A54-91A6-1A95E5593C33 Q37305684-475E15E4-24A9-4E4A-BC4A-5CC1ACA7BD1D Q37441863-88387590-E0E4-4349-995C-0126123B2286 Q37509663-9A81423B-C557-43D3-B8E1-4D114D88F934

P2860

Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).

http://www.wikidata.org/entity/Q37068858

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Validation of a brief measure ...... and Impairment Scale (OASIS).

@en

Validation of a brief measure ...... Severity and Impairment Scale

@nl

type

label

Validation of a brief measure ...... and Impairment Scale (OASIS).

@en

Validation of a brief measure ...... Severity and Impairment Scale

@nl

prefLabel

Validation of a brief measure ...... and Impairment Scale (OASIS).

@en

Validation of a brief measure ...... Severity and Impairment Scale

@nl

P1433

Q37068858-DA7D9F02-ED19-497B-A825-6191AEA98FF7

P1476

Q37068858-9E51F50E-7AA9-4A40-A985-1B700AB32CDC

P2093

Q37068858-66AEF6BB-7671-4772-9AE4-507837B142CB

Q37068858-89082CFA-5342-4876-8149-37DC48E4C175

Q37068858-912B3BFA-8D15-4DB6-AF25-B4FEDD5ABAB5

Q37068858-A20CFA1D-6CF1-46B6-B40D-86308A412EC3

Q37068858-B7850984-A54A-4ED6-A0CB-88EC9756AB5E

Q37068858-BDE37278-0AD1-4B1B-B3AA-590D985F4361

Q37068858-CD37BCE1-ABDE-4084-B0A8-148AFCE67053

Q37068858-D27882E4-B99E-49A8-AAAC-D4AE0631383D

Q37068858-DBA5C026-FE33-41D2-89A7-7600AC812438

Q37068858-FCC2F8E4-38CA-46C8-8A98-E49E890A8740

P2860

Q37068858-0D999BD0-26FF-42E0-88B2-D778028EC69B

Q37068858-4320EC75-FDC4-4238-A0D6-34F9759C7B59

Q37068858-44C957E6-6D96-45B3-BB65-08DBB7A9D35C

Q37068858-49E56C6F-D43F-4E7D-987E-60E7698FD4BD

Q37068858-55979FEE-D1F6-47DF-9613-E4F2965C93A1

Q37068858-55AD37C5-EDF0-4F7F-802A-5933A8480D92

Q37068858-5AFAAC26-2187-45F7-BC21-DF13CF2EDA90

Q37068858-6BE11292-CAC2-497C-97FD-6EE9E7009C2D

Q37068858-6C4C76D2-5833-42AC-A810-B96A2109714E

Q37068858-7BD8E083-44AD-4B73-BA3A-3EB4D327C8F2

P304

Q37068858-36909997-1D77-4C8B-9EFD-ED0164042065

P31

Q37068858-4FB3AF24-3F8B-4C90-A3DF-98CA3D69464C

P356

Q37068858-85ADACC8-9384-4765-81A0-E707FBCCB8D7

P433

Q37068858-F1F5A238-B20D-421C-ABB8-6E6CC0A9D3C1

P478

Q37068858-5E4103DA-6DFF-4DD2-BEAC-04848F5EE31B

P577

Q37068858-A1A61448-1653-4A04-8490-A8C4D5D5D186

P5875

Q37068858-C062E2D1-437D-4BC3-AE79-9D98884418C5

P698

Q37068858-4DDFE7BC-0977-4255-B8CE-789DFAD711DA

P932

Q37068858-2407C3C4-BFB5-45E9-A6A2-7E7E49D064CC

P356

J.JAD.2008.03.014

P1433

Journal of Affective Disorders

P1476

Validation of a brief measure ...... and Impairment Scale (OASIS).

@en

P2093

Alexander Bystritsky

http://www.w3.org/2001/XMLSchema#string

Ariel J Lang

http://www.w3.org/2001/XMLSchema#string

Cathy Sherbourne

http://www.w3.org/2001/XMLSchema#string

Denise A Chavira

http://www.w3.org/2001/XMLSchema#string

Greer Sullivan

http://www.w3.org/2001/XMLSchema#string

Laura Campbell-Sills

http://www.w3.org/2001/XMLSchema#string

Michelle G Craske

http://www.w3.org/2001/XMLSchema#string

Murray B Stein

http://www.w3.org/2001/XMLSchema#string

Peter Roy-Byrne

http://www.w3.org/2001/XMLSchema#string

Sonya B Norman

http://www.w3.org/2001/XMLSchema#string

P2860

The PHQ-9: validity of a brief depression severity measure

Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication

The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Quality of life in individuals with anxiety disorders.

Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.

Reliability of the self-report version of the panic disorder severity scale.

EQ-5D: a measure of health status from the EuroQol Group.

The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication

P304

92-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAD.2008.03.014

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5364788

http://www.w3.org/2001/XMLSchema#string

P698

18486238

http://www.w3.org/2001/XMLSchema#string

P932

2629402

http://www.w3.org/2001/XMLSchema#string